Shaanxi HuiKang Bio-tech Co.,Ltd.founded in 2001, focuses on the application research of Active Proteins and Peptides in the frontier field of biotechnology. The business scope includes protein and peptides raw materials, drug screening, medical device for tissue regeneration and repair, and functional skin care products. HuiKang has 70+ R&D team, and equipped with cutting-edge equipments. The self owned biological industry park covers an area of 43 acres, and has workshops for the production of recombinant proteins, synthetic peptides, cosmetics, and medical devices, which conform to system standards such as ISO9001, ISO22716, and ISO13485. Moreover, HuiKang can carry out large-scale production of multi-pipeline products. We have launched a HuiKang International Peptide Library which contained 175,000 clear peptide chains, and has unfolded screening projects of COVID-19 blocker peptide, Mass receptor, anti wrinkle analgesic peptide and whitening peptide. This unique drug screening method is now available for global drug screening collaboration. The company has developed tissue regeneration products such as wound repair, hair growth and bone repair, taking exosomes and recombinant collagen as materials, and verified exosomal drug delivery tools with mucopolysaccharidosis animal models. HuiKang obtained 102 authorized patents, which provide patent protection for peptide drug screening methods, large-scale extraction of exosomes, recombinant collagen and sponges, human lysozyme eye drops, absorbable biofilms, and sunscreen peptides,etc. HuiKang Bio-tech has a number of international partners, and developed the cooperative researches on novel anti-infection peptides drug discovery with Monash University, the Mg-wire reinforced rh-collagen in GBR with Queensland University of Technology, and cooperated and exchanged with Daegu University, WEHI, the University of Michigan, etc. Furthermore, HuiKang has hosted the International Conference of Protein and Peptides 2018.